BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 29307375)

  • 1. A three-dimensional in vitro HepG2 cells liver spheroid model for genotoxicity studies.
    Shah UK; Mallia JO; Singh N; Chapman KE; Doak SH; Jenkins GJS
    Mutat Res Genet Toxicol Environ Mutagen; 2018 Jan; 825():51-58. PubMed ID: 29307375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reprint of: A three-dimensional in vitro HepG2 cells liver spheroid model for genotoxicity studies.
    Shah UK; Mallia JO; Singh N; Chapman KE; Doak SH; Jenkins GJS
    Mutat Res Genet Toxicol Environ Mutagen; 2018 Oct; 834():35-41. PubMed ID: 30173862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptation of the in vitro micronucleus assay for genotoxicity testing using 3D liver models supporting longer-term exposure durations.
    Conway GE; Shah UK; Llewellyn S; Cervena T; Evans SJ; Al Ali AS; Jenkins GJ; Clift MJD; Doak SH
    Mutagenesis; 2020 Sep; 35(4):319-330. PubMed ID: 32780103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of urethane-induced genotoxicity in vitro using metabolically competent human 2D and 3D spheroid culture models.
    Shah UK; Verma JR; Chapman KE; Wilde EC; Tonkin JA; Brown MR; Johnson GE; Doak SH; Jenkins GJ
    Mutagenesis; 2020 Dec; 35(6):445-452. PubMed ID: 33219664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP1A1 and CYP1A2 expression levels are differentially regulated in three-dimensional spheroids of liver cancer cells compared to two-dimensional monolayer cultures.
    Terashima J; Goto S; Hattori H; Hoshi S; Ushirokawa M; Kudo K; Habano W; Ozawa S
    Drug Metab Pharmacokinet; 2015 Dec; 30(6):434-40. PubMed ID: 26643992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of in vitro 3D cell model from hepatocellular carcinoma (HepG2) cell line and its application for genotoxicity testing.
    Štampar M; Tomc J; Filipič M; Žegura B
    Arch Toxicol; 2019 Nov; 93(11):3321-3333. PubMed ID: 31542801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and reproducibility of HepG2 hanging drop spheroids toxicology in vitro.
    Hurrell T; Ellero AA; Masso ZF; Cromarty AD
    Toxicol In Vitro; 2018 Aug; 50():86-94. PubMed ID: 29476884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput micronucleus assay using three-dimensional HepaRG spheroids for in vitro genotoxicity testing.
    Seo JE; Li X; Le Y; Mei N; Zhou T; Guo X
    Arch Toxicol; 2023 Apr; 97(4):1163-1175. PubMed ID: 36847820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of an in vitro three-dimensional HepaRG spheroid model for genotoxicity testing using the high-throughput CometChip platform.
    Seo JE; He X; Muskhelishvili L; Malhi P; Mei N; Manjanatha M; Bryant M; Zhou T; Robison T; Guo X
    ALTEX; 2022; 39(4):583-604. PubMed ID: 35791290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of HepG2/C3A liver spheroids as a model system for genotoxicity studies.
    Coltman NJ; Coke BA; Chatzi K; Shepherd EL; Lalor PF; Schulz-Utermoehl T; Hodges NJ
    Toxicol Lett; 2021 Jul; 345():34-45. PubMed ID: 33865918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of Albumin Secretion and Metabolic Activity of Cytochrome P450 1A1 of Human Hepatoblastoma HepG2 Cells in Multicellular Spheroids by Controlling Spheroid Size.
    Nishikawa T; Tanaka Y; Nishikawa M; Ogino Y; Kusamori K; Mizuno N; Mizukami Y; Shimizu K; Konishi S; Takahashi Y; Takakura Y
    Biol Pharm Bull; 2017; 40(3):334-338. PubMed ID: 28250275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D spheroid cultures improve the metabolic gene expression profiles of HepaRG cells.
    Takahashi Y; Hori Y; Yamamoto T; Urashima T; Ohara Y; Tanaka H
    Biosci Rep; 2015 May; 35(3):. PubMed ID: 26182370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array.
    Tung YC; Hsiao AY; Allen SG; Torisawa YS; Ho M; Takayama S
    Analyst; 2011 Feb; 136(3):473-8. PubMed ID: 20967331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The comet assay applied to HepG2 liver spheroids.
    Elje E; Hesler M; Rundén-Pran E; Mann P; Mariussen E; Wagner S; Dusinska M; Kohl Y
    Mutat Res Genet Toxicol Environ Mutagen; 2019 Sep; 845():403033. PubMed ID: 31561895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3D hanging spheroid plate for high-throughput CAR T cell cytotoxicity assay.
    Chen Z; Han S; Sanny A; Chan DL; van Noort D; Lim W; Tan AH; Park S
    J Nanobiotechnology; 2022 Jan; 20(1):30. PubMed ID: 35012567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-assembled 3D spheroids and hollow-fibre bioreactors improve MSC-derived hepatocyte-like cell maturation in vitro.
    Cipriano M; Freyer N; Knöspel F; Oliveira NG; Barcia R; Cruz PE; Cruz H; Castro M; Santos JM; Zeilinger K; Miranda JP
    Arch Toxicol; 2017 Apr; 91(4):1815-1832. PubMed ID: 27590069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SpheroidChip: Patterned Agarose Microwell Compartments Harboring HepG2 Spheroids are Compatible with Genotoxicity Testing.
    Chao C; Ngo Le P; Engelward BP
    ACS Biomater Sci Eng; 2020 Apr; 6(4):2427-2439. PubMed ID: 33145399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ready to go 3D? A semi-automated protocol for microwell spheroid arrays to increase scalability and throughput of 3D cell culture testing.
    Basu A; Dydowiczová A; Trosko JE; Bláha L; Babica P
    Toxicol Mech Methods; 2020 Oct; 30(8):590-604. PubMed ID: 32713235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 3D in vitro model of differentiated HepG2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studies.
    Ramaiahgari SC; den Braver MW; Herpers B; Terpstra V; Commandeur JN; van de Water B; Price LS
    Arch Toxicol; 2014 May; 88(5):1083-95. PubMed ID: 24599296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High throughput generating stable spheroids with tip-refill wafer.
    Yang X; Pan R; Ning K; Xie Y; Chen F; Sun W; Yu L
    Biotechnol J; 2024 Feb; 19(2):e2300427. PubMed ID: 38403449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.